Suzanne Bennett, DO
Family Medicine · Glendale, AZNPI 1881659936
Payments from drug & device makers
Across 128 payments — averaging $44.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$669
- Novo Nordisk$454
- Abbott$377
- Amgen$331
- plus $783 from 12 others
What the payments were for
- Consulting fees$1,20021%
- Food & beverage$4,43479%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $1,696 |
| Biohaven Pharmaceuticals, Inc. | 3 | $1,324 |
| AbbVie(2 entities) | 29 | $669 |
| Novo Nordisk | 19 | $454 |
| Abbott | 18 | $377 |
| Amgen | 9 | $331 |
| Teva Pharmaceuticals USA, Inc. | 10 | $202 |
| Pfizer | 4 | $143 |
| Idorsia Pharmaceuticals US Inc | 4 | $132 |
| GSK | 1 | $125 |
| Boston Scientific | 4 | $68 |
| Lilly USA, LLC | 2 | $26 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Nevro Corp. | 1 | $14 |
| Phadia US Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,634 in reported general payments places this provider in the 90th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $14,920 |
| Levothyroxine Sodium | 66 | $607 |
| Ezetimibe | 15 | $563 |
| Omeprazole | 26 | $294 |
| Rosuvastatin Calcium | 43 | $272 |
| Atorvastatin Calcium | 47 | $247 |
| Metoprolol Succinate | 21 | $236 |
| Simvastatin | 26 | $235 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 11 | $235 |
| Lisinopril | 33 | $235 |
| Metformin Hcl ErMetformin Hcl | 25 | $209 |
| Tamsulosin Hcl | 13 | $192 |
| Pantoprazole Sodium | 15 | $168 |
| Losartan Potassium | 26 | $157 |
| Metformin Hcl | 20 | $132 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Glendale
- Thomas LenzmeierGlendale$4.5M
- Rachel LanglandGlendale$83K
- Danielle ArmasScottsdale$73M
- Terry O'ReillyMesa$35.8M
- Shawn SearleChandler$27M
- Corey AndersonMesa$21.5M
- Dena PetersenTucson$14.7M
- Gerald ShockeyMesa$12.3M
- Brock MerrittPhoenix$8.4M
- John McGettiganTucson$8.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.